Thus, our study identified a novel KDM5D/p38/COX-2 pathway in regulating CHK1i sensitivity in PC cells, whereby reduced KDM5D expression promoted p38/COX-2 activity and increased resistance to CHK1is. The gene discussed is KDM5D; the disease is pachyonychia congenita.